These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7887373)

  • 1. Factors influencing the delivery of pharmacy services.
    Miller MJ; Ortmeier BG
    Am Pharm; 1995 Jan; NS35(1):39-45. PubMed ID: 7887373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profitability, third-party reimbursement, and access to community pharmacies.
    Carroll NV; Miederhoff PA; Waters LW
    Clin Ther; 1996; 18(4):703-15; discussion 702. PubMed ID: 8879898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient counseling in community pharmacy and its relationship with prescription payment methods and practice settings.
    Raisch DW
    Ann Pharmacother; 1993 Oct; 27(10):1173-9. PubMed ID: 8251681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Third-party reimbursement for generic prescription drugs: The prevalence of below-cost reimbursement in an environment of maximum allowable cost-based reimbursement.
    Murry L; Gerleman B; Urick B; Urmie J
    J Am Pharm Assoc (2003); 2018; 58(4):421-425. PubMed ID: 29861152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacists' Experiences, Perceptions, and Knowledge of Direct-to-Consumer Prescription Coupons.
    Gernant SA; Polomoff CM; Marsh J; Martineau S; Hardie C; Jeffery SM
    J Manag Care Spec Pharm; 2020 Sep; 26(9):1130-1137. PubMed ID: 32857654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying relationships between the professional culture of pharmacy, pharmacists' personality traits, and the provision of advanced pharmacy services.
    Rosenthal M; Tsao NW; Tsuyuki RT; Marra CA
    Res Social Adm Pharm; 2016; 12(1):56-67. PubMed ID: 26050916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How might the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 affect the financial viability of rural pharmacies? An analysis of preimplementation prescription volume and payment sources in rural and urban areas.
    Fraher EP; Slifkin RT; Smith L; Randolph R; Rudolf M; Holmes GM
    J Rural Health; 2005; 21(2):114-21. PubMed ID: 15859048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of prescription reimbursement methodologies in Japan and the United States.
    Akaho E; MacLaughlin EJ; Takeuchi Y
    J Am Pharm Assoc (2003); 2003; 43(4):519-26. PubMed ID: 12952317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of pharmacy and pharmacist characteristics on the secondary prevention of cardiovascular disease.
    Puspitasari HP; Aslani P; Krass I
    Int J Clin Pharm; 2015 Oct; 37(5):834-43. PubMed ID: 25964140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Financial impact of patients enrolled in a medication adherence program at an independent community pharmacy.
    Clifton CL; Branham AR; Hayes HH; Moose JS; Rhodes LA; Marciniak MW
    J Am Pharm Assoc (2003); 2018; 58(4S):S109-S113. PubMed ID: 30006182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimating pharmacy level prescription drug acquisition costs for third-party reimbursement.
    Kreling DH; Kirk KW
    Med Care; 1986 Jul; 24(7):590-600. PubMed ID: 3523065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacy-based hypertension care employing mHealth in Lagos, Nigeria - a mixed methods feasibility study.
    Nelissen HE; Cremers AL; Okwor TJ; Kool S; van Leth F; Brewster L; Makinde O; Gerrets R; Hendriks ME; Schultsz C; Osibogun A; Van't Hoog AH
    BMC Health Serv Res; 2018 Dec; 18(1):934. PubMed ID: 30514376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmaceutical care in community pharmacies: practice and research in Canada.
    Jones EJ; Mackinnon NJ; Tsuyuki RT
    Ann Pharmacother; 2005 Sep; 39(9):1527-33. PubMed ID: 16014374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimating the impact of Medicare part D on the profitability of independent community pharmacies.
    Carroll NV
    J Manag Care Pharm; 2008 Oct; 14(8):768-79. PubMed ID: 18983206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consumer and provider evaluation of rural pharmacy services.
    Straub LA; Straub SA
    J Rural Health; 1999; 15(4):403-12. PubMed ID: 10808634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationships among prescription payment methods and interactions between community pharmacists and prescribers.
    Raisch DW
    Ann Pharmacother; 1992; 26(7-8):902-6. PubMed ID: 1504395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basic terminology in obtaining reimbursement for pharmacists' cognitive services.
    Nutescu EA; Klotz RS
    Am J Health Syst Pharm; 2007 Jan; 64(2):186-92. PubMed ID: 17215470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Organizational factors influencing pharmacy practice change.
    Doucette WR; Nevins JC; Gaither C; Kreling DH; Mott DA; Pedersen CA; Schommer JC
    Res Social Adm Pharm; 2012; 8(4):274-84. PubMed ID: 21958467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Actual and perceived provision of pharmaceutical care in Danish community pharmacies: the pharmacists' opinions.
    Rossing C; Hansen EH; Traulsen JM; Krass I
    Pharm World Sci; 2005 Jun; 27(3):175-81. PubMed ID: 16096884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Community pharmacists' perceptions about pharmaceutical care of OTC western medicine: a survey in Harbin of China.
    Song M; Ung CO; Hu H; Wang Y
    Int J Clin Pharm; 2015 Dec; 37(6):1014-20. PubMed ID: 26286338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.